当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-06-27 , DOI: 10.1056/nejmoa2313318 Marc E. Rothenberg 1 , Evan S. Dellon 1 , Margaret H. Collins 1 , Albert J. Bredenoord 1 , Ikuo Hirano 1 , Kathryn A. Peterson 1 , Laura Brooks 1 , Julie M. Caldwell 1 , Harald Fjällbrant 1 , Hanna Grindebacke 1 , Calvin N. Ho 1 , Matthew Keith 1 , Christopher McCrae 1 , Dominic Sinibaldi 1 , Wendy I. White 1 , Catherine J. Datto 1
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-06-27 , DOI: 10.1056/nejmoa2313318 Marc E. Rothenberg 1 , Evan S. Dellon 1 , Margaret H. Collins 1 , Albert J. Bredenoord 1 , Ikuo Hirano 1 , Kathryn A. Peterson 1 , Laura Brooks 1 , Julie M. Caldwell 1 , Harald Fjällbrant 1 , Hanna Grindebacke 1 , Calvin N. Ho 1 , Matthew Keith 1 , Christopher McCrae 1 , Dominic Sinibaldi 1 , Wendy I. White 1 , Catherine J. Datto 1
Affiliation
Benralizumab is an eosinophil-depleting anti–interleukin-5 receptor α monoclonal antibody. The efficacy and safety of benralizumab in patients with eosinophilic esophagitis are unclear.In a phase 3...
中文翻译：
使用贝那利珠单抗消除嗜酸性粒细胞治疗嗜酸性粒细胞性食管炎
Benralizumab 是一种消耗嗜酸性粒细胞的抗白细胞介素 5 受体 α 单克隆抗体。贝那利珠单抗对嗜酸性粒细胞性食管炎患者的疗效和安全性尚不清楚。在 3 期试验中...
更新日期：2024-06-27
中文翻译：
使用贝那利珠单抗消除嗜酸性粒细胞治疗嗜酸性粒细胞性食管炎
Benralizumab 是一种消耗嗜酸性粒细胞的抗白细胞介素 5 受体 α 单克隆抗体。贝那利珠单抗对嗜酸性粒细胞性食管炎患者的疗效和安全性尚不清楚。在 3 期试验中...
京公网安备 11010802027423号